Literature DB >> 27123281

Aplastic anemia associated with severe hemorrhagic cystitis following radiotherapy for prostate cancer.

Taito Nakano1, Kouji Izumi1, Aerken Maolake1, Ariunbold Natsagdorji1, Hiroaki Iwamoto1, Yasuhide Kitagawa1, Yoshifumi Kadono1, Hiroyuki Konaka1, Atsushi Mizokami1, Mikio Namiki1.   

Abstract

Hemorrhagic cystitis is a rare complication following radiotherapy for intrapelvic cancer types, including cervical cancer, bladder cancer and prostate cancer. The severity of hemorrhagic cystitis is different in each case, although symptoms improve spontaneously in certain cases, and often significant morbidity requiring numerous interventions occurs. Since no treatment strategy exists with high evidences for such severe hemorrhagic cystitis, urologists have difficulty in solving the bleeding and pain, which the patients suffer. Aplastic anemia is a rare blood disorder, with an incidence reported as 2/1 million individuals annually. Patients have a risk of diffuse bleeding for presentation with anemia, thrombocytopenia and neutropenia. The present report presented a case of severe hemorrhagic cystitis remitted successfully by the treatment for underlying aplastic anemia.

Entities:  

Keywords:  aplastic anemia; hemorrhagic cystitis; prostate cancer; radiation cystitis; radiotherapy

Year:  2016        PMID: 27123281      PMCID: PMC4840553          DOI: 10.3892/mco.2016.791

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  15 in total

1.  Intravesical instillation of maalox for the treatment of hemorrhagic cystitis.

Authors:  K Kawagoe; T Kawana
Journal:  Asia Oceania J Obstet Gynaecol       Date:  1989-03

2.  Late rectal and bladder toxicity following radiation therapy for prostate cancer: Predictive factors and treatment results.

Authors:  Rafael Fuentes-Raspall; José Maria Inoriza; Alvaro Rosello-Serrano; Carmen Auñón-Sanz; Pilar Garcia-Martin; Gemma Oliu-Isern
Journal:  Rep Pract Oncol Radiother       Date:  2013-06-21

3.  Late recurrence after radical cystectomy: patterns, risk factors and outcomes.

Authors:  Brian J Linder; Stephen A Boorjian; Tvrtko Hudolin; John C Cheville; Prabin Thapa; Robert F Tarrell; Igor Frank
Journal:  J Urol       Date:  2013-12-10       Impact factor: 7.450

Review 4.  Recent developments in drug therapy for aplastic anemia.

Authors:  Lauren Willis; Amber Rexwinkle; Jeffrey Bryan; Tapan M Kadia
Journal:  Ann Pharmacother       Date:  2014-09-02       Impact factor: 3.154

5.  Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis.

Authors:  Edward Riachy; Lucas Krauel; Barrie S Rich; Maureen P McEvoy; Joshua N Honeyman; Farid Boulad; Suzanne L Wolden; Harry W Herr; Michael P La Quaglia
Journal:  J Urol       Date:  2013-08-13       Impact factor: 7.450

Review 6.  Mechanisms of hemorrhagic cystitis.

Authors:  Subhash Haldar; Christopher Dru; Neil A Bhowmick
Journal:  Am J Clin Exp Urol       Date:  2014-10-02

7.  An unusual complication of silver nitrate treatment of hemorrhagic cystitis: case report.

Authors:  G R Jerkins; H N Noe; D E Hill
Journal:  J Urol       Date:  1986-08       Impact factor: 7.450

8.  [Successful treatment of hemorrhagic cystitis after radiation therapy with intravesical instillation of aluminium hydroxide gel and magnesium hydroxide: report of a case].

Authors:  Norihiko Kawamura; Yoichi Kakuta; Sinichiro Fukuhara; Tetsuo Imazu; Tsuneo Hara; Seiji Yamaguchi
Journal:  Hinyokika Kiyo       Date:  2008-03

9.  Findings at cystoscopy performed for cause after prostate brachytherapy.

Authors:  Michael S Leapman; Richard G Stock; Nelson N Stone; Simon J Hall
Journal:  Urology       Date:  2014-04-03       Impact factor: 2.649

10.  Aluminum toxicity following intravesical alum irrigation for hemorrhagic cystitis.

Authors:  V S Kanwar; J J Jenkins; B N Mandrell; W L Furman
Journal:  Med Pediatr Oncol       Date:  1996-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.